Author of the publication

Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus.

, , , , , , , , and . Journal of Biological Chemistry, 282 (41): 30051--30061 (October 2007)
DOI: 10.1074/jbc.M704247200

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

High-Fat Diet-Induced Complement Activation Mediates Intestinal Inflammation and Neoplasia, Independent of Obesity., , , , , , , and . Molecular cancer research : MCR, 14 (10): 953--965 (October 2016)Complement deposits on ocular tissues adjacent to sites of inflammation., , , , , , and . Current Eye Research, 32 (11): 917--922 (November 2007)Complement Involvement in Periodontitis: Molecular Mechanisms and Rational Therapeutic Approaches., , , , and . Adv.Exp.Med.Biol., (2015)Progress and Trends in Complement Therapeutics., and . Adv.Exp.Med.Biol., 735 (Chapter 1): 1--22 (2013)Illuminating the latest advances in innate immunity on the island of the sun god., and . Expert review of clinical immunology, page 875--878. University of Louisville, Oral Health and Systemic Disease, Louisville, KY, USA., (November 2010)Complement in immune and inflammatory disorders: therapeutic interventions., and . Journal of immunology (Baltimore, Md. : 1950), 190 (8): 3839--3847 (April 2013)Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles., , , , , , , , and . 35 (11): 3688--3696 (April 2014)Complement-activation fragment C4a mediates effector functions by binding as untethered agonist to protease-activated receptors 1 and 4., , and . Proceedings of the National Academy of Sciences, 114 (41): 10948--10953 (October 2017)Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: Implications for treatment of malarial anemia., , , , , , and . Clinical immunology (Orlando, Fla.), (October 2016)Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?, , , , , , , , , and 6 other author(s). Stem cells (Dayton, Ohio), 32 (9): 2430--2442 (September 2014)